A
Amerise Biosciences Ltd
BSE:531681
Amerise Biosciences Ltd
BSE:531681
Price:
0.69
INR
-1.43%
Market Closed
Market Cap:
₹45.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Amerise Biosciences Ltd
BSE:531681
|
IN |
|
N
|
Netflix Inc
XETRA:NFC
|
US |
|
Affinity Gold Corp
OTC:AFYG
|
US |
Income Statement
Earnings Waterfall
Amerise Biosciences Ltd
Amerise Biosciences Ltd
Income Statement
Amerise Biosciences Ltd
Amerise Biosciences Ltd
Currency: INR
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Revenue |
90
N/A
|
75
-17%
|
56
-25%
|
56
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+35 800%
|
0
N/A
|
0
0%
|
0
N/A
|
1
N/A
|
1
N/A
|
1
N/A
|
|
| Gross Profit | |||||||||||||||
| Cost of Revenue |
(89)
|
(77)
|
(63)
|
(63)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gross Profit |
1
N/A
|
(2)
N/A
|
(6)
-156%
|
(6)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+35 800%
|
0
N/A
|
0
0%
|
0
N/A
|
1
N/A
|
1
N/A
|
1
N/A
|
|
| Operating Income | |||||||||||||||
| Operating Expenses |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
|
| Selling, General & Administrative |
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Operating Expenses |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
|
| Operating Income |
(0)
N/A
|
(4)
-1 827%
|
(7)
-86%
|
(7)
-3%
|
(1)
+83%
|
(1)
+13%
|
(1)
-8%
|
(1)
-21%
|
(1)
+49%
|
(0)
+60%
|
(2)
-501%
|
(1)
+22%
|
(2)
-54%
|
(2)
-9%
|
|
| Pre-Tax Income | |||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
6
|
6
|
6
|
9
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
3
|
3
|
|
| Pre-Tax Income |
5
N/A
|
2
-61%
|
(1)
N/A
|
2
N/A
|
(1)
N/A
|
(1)
+7%
|
(1)
-8%
|
(1)
-22%
|
(1)
+49%
|
(0)
+60%
|
0
N/A
|
0
+534%
|
0
-18%
|
1
+65%
|
|
| Net Income | |||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
5
|
2
|
(1)
|
2
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
0
|
0
|
1
|
|
| Net Income (Common) |
5
N/A
|
2
-61%
|
(1)
N/A
|
2
N/A
|
(1)
N/A
|
(1)
+7%
|
(1)
-8%
|
(1)
-22%
|
(1)
+49%
|
(0)
+60%
|
0
N/A
|
0
+712%
|
0
-19%
|
1
+68%
|
|
| EPS (Diluted) |
0.08
N/A
|
0.03
-63%
|
-0.02
N/A
|
0.03
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.02
N/A
|
-0.01
+50%
|
0
N/A
|
0
N/A
|
0
N/A
|
0.01
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
